Welche intrazerebralen Blutungen sollte man operativ behandeln?

Kernaussagen

• Bei ICB-Patienten mit einem GCS von 9 – 13 kann eine operative Therapie eine sinnvolle Therapieoption sein.

• Die Auswahl des geeigneten Therapieverfahrens (Kraniotomie, Endoskopie, Kathetereinlage, externe Ventrikeldrainage) sollte von Fall zu Fall diskutiert werden. Zu fordern ist aber die Verwendung der Neuronavigation zur Senkung der zugangsassoziierten Morbidität.

• Vor einer operativen Therapie sollte man spezifische Gerinnungstests durchführen, medikamenteninduzierte Gerinnungsstörungen ausgleichen und einen entgleisten Blutdruck normalisieren.

• Literatur

• 1 Mendelow AD, Gregson BA, Fernandes HM et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365: 387-397
• 2 Mendelow AD, Gregson BA, Rowan EN et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 2013; 382: 397-408
• 3 Nagasaka T, Tsugeno M, Ikeda H et al. Balanced irrigation-suction technique with a multifunctional suction cannula and its application for intraoperative hemorrhage in endoscopic evacuation of intracerebral hematomas: technical note. Neurosurgery 2009; 65: E826-827; discussion E827
• 4 Messerer M, Daniel RT, Oddo M. Neuromonitoring after major neurosurgical procedures. Minerva Anestesiol 2012; 78: 810-822
• 5 Enchev Y. Neuronavigation: geneology, reality, and prospects. Neurosurg Focus 2009; 27: E11
• 6 Stein M, Misselwitz B, Hamann GF et al. Intracerebral hemorrhage in the very old: future demographic trends of an aging population. Stroke 2012; 43: 1126-1128
• 7 Langhorne P, Fearon P, Ronning OM et al. Stroke unit care benefits patients with intracerebral hemorrhage: systematic review and meta-analysis. Stroke 2013; 44: 3044-3049
• 8 Beynon C, Jakobs M, Rizos T et al. Rapid bedside coagulometry prior to urgent neurosurgical procedures in anticoagulated patients. Br J Neurosurg 2014; 28: 29-33
• 9 Beynon C, Sakowitz OW, Unterberg AW. Multiple electrode aggregometry in antiplatelet-related intracerebral haemorrhage. J Clin Neurosci 2013; 20: 1805-1806
• 10 Campbell PG, Sen A, Yadla S et al. Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review. World Neurosurg 2010; 74: 279-285
• 11 Sprigg N, Renton CJ, Dineen RA et al. Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461). J Stroke Cerebrovasc Dis 2014; 23: 1312-1318
• 12 Mayer SA, Davis SM, Skolnick BE et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?. Stroke 2009; 40: 833-840
• 13 Le Roux P, Pollack CV, Milan M et al. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage. J Neurosurg 2014; 121: 1-20
• 14 Bershad EM, Suarez JI. Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature. Neurocrit Care 2010; 12: 403-413
• 15 Anderson CS, Heeley E, Huang Y et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368: 2355-2365
• 16 Fung C, Murek M, Z’Graggen WJ et al. Decompressive hemicraniectomy in patients with supratentorial intracerebral hemorrhage. Stroke 2012; 43: 3207-3211
• 17 Butcher KS, Baird T, MacGregor L et al. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke 2004; 35: 1879-1885
• 18 Orakcioglu B, Kentar MM, Schiebel P et al. Perihemorrhagic Ischemia Occurs in a Volume-Dependent Manner as Assessed by Multimodal Cerebral Monitoring in a Porcine Model of Intracerebral Hemorrhage. Neurocrit Care 2014; [Epub ahead of print]
• 19 Mould WA, Carhuapoma JR, Muschelli J et al. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke 2013; 44: 627-634
• 20 Kirollos RW, Tyagi AK, Ross SA et al. Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery 2001; 49: 1378-1386 discussion 1386–1387
• 21 Mathew P, Teasdale G, Bannan A et al. Neurosurgical management of cerebellar haematoma and infarct. J Neurol Neurosurg Psychiatr 1995; 59: 287-292
• 22 Da Pian R, Bazzan A, Pasqualin A. Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases. Neurol Res 1984; 6: 145-151
• 23 Orakcioglu B, Beynon C, Bösel J et al. Minimally Invasive Endoscopic Surgery for Treatment of Spontaneous Intracerebral Hematomas: A Single-Center Analysis. Neurocrit Care 2014; 12: 407-416
• 24 Steiner T, Al-Shahi Salman R, Beer R et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 2014; 9: 840-855
• 25 Carvi y Nievas MN. Why, when, and how spontaneous intracerebral hematomas should be operated. Med Sci Monit 2005; 11: RA24-31